Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer's.
Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):411-417. doi: 10.1080/17425255.2024.2357637. Epub 2024 May 20.
Expert Opin Drug Metab Toxicol. 2024.
PMID: 38758223
Review.
Profiling lecanemab as a treatment option for Alzheimer's disease.
Schiller ER, Silverglate BD, Grossberg GT.
Schiller ER, et al. Among authors: silverglate bd.
Expert Rev Neurother. 2024 May;24(5):433-441. doi: 10.1080/14737175.2024.2333970. Epub 2024 Apr 3.
Expert Rev Neurother. 2024.
PMID: 38566584
Review.
Item in Clipboard
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?
Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.
Beveridge J, et al. Among authors: silverglate bd.
Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.
Expert Opin Emerg Drugs. 2024.
PMID: 38193477
Review.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.